created_at Aug 6, 2026, 12:48 AM UTC
ingested_at Aug 6, 2026, 12:48 AM UTC
providers gdelt
source leaderpost.com
provider_count 1
source_slug leaderpost-com
url https://leaderpost.com/press-releases/business-wire/u-s-fda-approves-takedas-orzeyful-oveporexton-the-first-and-only-medicine-to-treat-the-underlying-cause-of-narcolepsy-type-1
country Canada
language English
org_id 0ac7c1ae-d6eb-4868-9eb4-96b085d4f7ba
dedup_key 73b2dfc8e9eed65d
keywords approves takeda, cause narcolepsy, fda approves, medicine treat, narcolepsy type, orzeyful oveporexton, oveporexton medicine, takeda orzeyful, treat underlying, underlying cause
last_modified_at Aug 6, 2026, 12:48 AM UTC
provider gdelt
feed_section Technology
published_at Aug 5, 2026, 11:45 PM UTC